Cargando…
The Challenge of Assessing Adherence to Subcutaneous Biological Drugs in Immune-Mediated Inflammatory Diseases. Letter to the Editor Regarding Michetti P, Weinman J, Mrowietz U, et al. Adv Ther (2017);34:91–108. doi:10.1007/s12325-016-0441-3
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599446/ https://www.ncbi.nlm.nih.gov/pubmed/28819910 http://dx.doi.org/10.1007/s12325-017-0602-z |
| _version_ | 1783264057672859648 |
|---|---|
| author | Cea-Calvo, Luis Carmona, Loreto Calvo-Alén, Jaime |
| author_facet | Cea-Calvo, Luis Carmona, Loreto Calvo-Alén, Jaime |
| author_sort | Cea-Calvo, Luis |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5599446 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-55994462017-10-03 The Challenge of Assessing Adherence to Subcutaneous Biological Drugs in Immune-Mediated Inflammatory Diseases. Letter to the Editor Regarding Michetti P, Weinman J, Mrowietz U, et al. Adv Ther (2017);34:91–108. doi:10.1007/s12325-016-0441-3 Cea-Calvo, Luis Carmona, Loreto Calvo-Alén, Jaime Adv Ther Letter Springer Healthcare 2017-08-17 2017 /pmc/articles/PMC5599446/ /pubmed/28819910 http://dx.doi.org/10.1007/s12325-017-0602-z Text en © The Author(s) 2017 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Letter Cea-Calvo, Luis Carmona, Loreto Calvo-Alén, Jaime The Challenge of Assessing Adherence to Subcutaneous Biological Drugs in Immune-Mediated Inflammatory Diseases. Letter to the Editor Regarding Michetti P, Weinman J, Mrowietz U, et al. Adv Ther (2017);34:91–108. doi:10.1007/s12325-016-0441-3 |
| title | The Challenge of Assessing Adherence to Subcutaneous Biological Drugs in Immune-Mediated Inflammatory Diseases. Letter to the Editor Regarding Michetti P, Weinman J, Mrowietz U, et al. Adv Ther (2017);34:91–108. doi:10.1007/s12325-016-0441-3 |
| title_full | The Challenge of Assessing Adherence to Subcutaneous Biological Drugs in Immune-Mediated Inflammatory Diseases. Letter to the Editor Regarding Michetti P, Weinman J, Mrowietz U, et al. Adv Ther (2017);34:91–108. doi:10.1007/s12325-016-0441-3 |
| title_fullStr | The Challenge of Assessing Adherence to Subcutaneous Biological Drugs in Immune-Mediated Inflammatory Diseases. Letter to the Editor Regarding Michetti P, Weinman J, Mrowietz U, et al. Adv Ther (2017);34:91–108. doi:10.1007/s12325-016-0441-3 |
| title_full_unstemmed | The Challenge of Assessing Adherence to Subcutaneous Biological Drugs in Immune-Mediated Inflammatory Diseases. Letter to the Editor Regarding Michetti P, Weinman J, Mrowietz U, et al. Adv Ther (2017);34:91–108. doi:10.1007/s12325-016-0441-3 |
| title_short | The Challenge of Assessing Adherence to Subcutaneous Biological Drugs in Immune-Mediated Inflammatory Diseases. Letter to the Editor Regarding Michetti P, Weinman J, Mrowietz U, et al. Adv Ther (2017);34:91–108. doi:10.1007/s12325-016-0441-3 |
| title_sort | challenge of assessing adherence to subcutaneous biological drugs in immune-mediated inflammatory diseases. letter to the editor regarding michetti p, weinman j, mrowietz u, et al. adv ther (2017);34:91–108. doi:10.1007/s12325-016-0441-3 |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599446/ https://www.ncbi.nlm.nih.gov/pubmed/28819910 http://dx.doi.org/10.1007/s12325-017-0602-z |
| work_keys_str_mv | AT ceacalvoluis thechallengeofassessingadherencetosubcutaneousbiologicaldrugsinimmunemediatedinflammatorydiseaseslettertotheeditorregardingmichettipweinmanjmrowietzuetaladvther20173491108doi101007s1232501604413 AT carmonaloreto thechallengeofassessingadherencetosubcutaneousbiologicaldrugsinimmunemediatedinflammatorydiseaseslettertotheeditorregardingmichettipweinmanjmrowietzuetaladvther20173491108doi101007s1232501604413 AT calvoalenjaime thechallengeofassessingadherencetosubcutaneousbiologicaldrugsinimmunemediatedinflammatorydiseaseslettertotheeditorregardingmichettipweinmanjmrowietzuetaladvther20173491108doi101007s1232501604413 AT ceacalvoluis challengeofassessingadherencetosubcutaneousbiologicaldrugsinimmunemediatedinflammatorydiseaseslettertotheeditorregardingmichettipweinmanjmrowietzuetaladvther20173491108doi101007s1232501604413 AT carmonaloreto challengeofassessingadherencetosubcutaneousbiologicaldrugsinimmunemediatedinflammatorydiseaseslettertotheeditorregardingmichettipweinmanjmrowietzuetaladvther20173491108doi101007s1232501604413 AT calvoalenjaime challengeofassessingadherencetosubcutaneousbiologicaldrugsinimmunemediatedinflammatorydiseaseslettertotheeditorregardingmichettipweinmanjmrowietzuetaladvther20173491108doi101007s1232501604413 |